ELTLGEFLKL

ELTLGEFLKL is a survivin peptide. ELTLGEFLKL shows significant stabilization of HLA-A*0201. ELTLGEFLKL can be used in the research of tumor immunotherapy[1].

Product Specifications

CAS Number

[303068-29-3]

UNSPSC

12352209

Target

MHC; Survivin

Related Pathways

Apoptosis; Immunology/Inflammation

Field of Research

Cancer; Inflammation/Immunology

Smiles

O=C(N[C@@H](CC(C)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCC(O)=O)N

Molecular Formula

C55H91N11O16

Molecular Weight

1162.38

References & Citations

[1]Schmitz M, et al. Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res. 2000 Sep 1;60 (17) :4845-9.